The National Institutes of Health (NIH), National Science Foundation (NSF), and U.S. Department of Agriculture (USDA) require certain categories of re...
Sponsor-patient engagement can play a pivotal role in the development of safe, effective, and clinically relevant new medicines. Increasingly, clinica...
Disaster preparedness and business continuity planning are essential for any research organization and required for organizations that receive Nationa...
The course is intended for currently Certified IRB Professionals (CIPs) seeking CIP continuing education (CE) credits for recertification. These modul...
Protocol Registration and Results Summary Disclosure in ClinicalTrials.gov is a video-enhanced guide to compliance with the FDAAA Final Rule and NIH ...
Good Documentation Practices (GDP) are critical for compliance with current Good Manufacturing Practices (cGMP) regulations and within organizations i...
Recently, there have been updates to ClinicalTrials.gov enforcement and various initiatives to drive transparency. Institutions are challenged to buil...
Protracted clinical trial agreement (CTA) negotiations often delay the start of a study. Understanding each party’s motivation and expectations faci...
Federal funding agencies, including the National Institutes of Health (NIH), National Science Foundation (NSF), and U.S. Department of Agriculture (US...
